Alessandra Pohlmann
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Myostatin is associated with the presence and development of acute-on-chronic liver failure.
Journal: JHEP reports : innovation in hepatology
Published: August 02, 2022
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
Journal: Clinical and translational gastroenterology
Published: April 03, 2019
Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 23, 2019
Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality.
Journal: Alimentary pharmacology & therapeutics
Published: January 20, 2019
Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis.
Journal: Frontiers in immunology
Published: October 30, 2018
Circulating microbiome in blood of different circulatory compartments.
Journal: Gut
Published: February 08, 2018
Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis.
Journal: PloS one
Published: January 15, 2018
Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.
Journal: PloS one
Published: December 08, 2017
Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: November 29, 2017
Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
Journal: Hepatology (Baltimore, Md.)
Published: July 05, 2017
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 03, 2017
Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality.
Journal: Hepatology (Baltimore, Md.)
Published: June 30, 2017
Last Updated: 09/26/2026